SCHEMBL2421908

SCHEMBL2421908

Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2OCc2ccc3ccccc3c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.57
HSD17B10 Q99714 2/20 0.57
LMNA P02545 2/20 0.57
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
POLB P06746 2/20 0.50
MAPT P10636 4/20 0.49
ALDH1A1 P00352 4/20 0.49
HPGD P15428 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ALPL P05186 1/20 0.48
RXFP1 Q9HBX9 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
AR P10275 1/20 0.47
TSHR P16473 1/20 0.47
CASP1 P29466 1/20 0.47
CCR4 P51679 1/20 0.47
PIK3CD O00329 2/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038511 0.88 KDM4E (0.66) KDM4EHSD17B10LMNAMEN1KMT2A
SCHEMBL2423013 0.87 KDM4E (0.51) KDM4EHSD17B10LMNAMEN1KMT2A
SCHEMBL6038787 0.86 AR (0.48) KDM4ELMNAMEN1KMT2APOLB
SCHEMBL2426819 0.85 MEN1 (0.56) KDM4EHSD17B10LMNAMEN1KMT2A
SCHEMBL2422289 0.85 MEN1 (0.55) KDM4EHSD17B10LMNAMEN1KMT2A
SCHEMBL6039123 0.85 KDM4E (0.59) KDM4EHSD17B10LMNAMEN1KMT2A
SCHEMBL6039214 0.85 CCR4 (0.64) KDM4EMEN1KMT2AMAPTALDH1A1
SCHEMBL6038910 0.82 KDM4E (0.56) KDM4EHSD17B10LMNAMEN1KMT2A
SCHEMBL2421332 0.81 KMT2A (0.59) KDM4EHSD17B10LMNAMEN1KMT2A
SCHEMBL2419196 0.81 EDNRA (0.46) KDM4EHSD17B10LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374802-B1 KYNURENINE PRODUCTION INHIBITOR KYOWA HAKKO KIRIN CO LTD (JP) 2014-04-23 EP disclosed
US-8673908-B2 Kynurenine production inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-03-18 US disclosed
EP-2374802-A1 KYNURENINE PRODUCTION INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2011-10-12 EP disclosed
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYOWA KIRIN CO., LTD. (JP) 2011-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYNU, KMO, IDO1 KDM4E 755/4885HSD17B10 497/4885LMNA 4183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.